- βIdentified a %CV threshold of 40.7% associated with severe hypoglycemia, giving T1D patients a concrete CGM warning signal
- βFindings closely align with ADA's recommended %CV target of under 36%, strengthening confidence in this metric for US clinical practice
- βUsed blinded CGM data from a rigorous randomized controlled trial, making the results more objective and clinically trustworthy
| Country | Japan |
| Journal | Journal of diabetes science and technology |
| Year | 2026 |
| Authors | Murata, Matsuhisa, Kuroda |
| PMID | 39960254 |
Japan Study: How Blood Sugar Variability Predicts Dangerous Lows in Type 1 Diabetes
A study from Japan has shed new light on how a single glucose monitoring metric β called the percent coefficient of variation (%CV) β may help predict dangerous low blood sugar episodes in people living with Type 1 diabetes (T1D). Conducted by researchers at the Department of Clinical Nutrition, NHO Kyoto Medical Center in Kyoto, this research adds important nuance to how continuous glucose monitors (CGMs) can be used not just to track averages, but to anticipate risk.
What the Researchers Studied
The team analyzed CGM data from 93 patients with Type 1 diabetes who were using multiple daily injections (MDIs) of insulin. All patients wore blinded CGMs β meaning the devices recorded data without showing it to the patient β over an 84-day control period. This data came from the larger ISCHIA study, a randomized controlled trial designed to evaluate how intermittent-scanning CGMs affect hypoglycemia prevention and quality of life in T1D patients.
The researchers focused on %CV, a measure of how wildly blood sugar levels swing up and down. Think of it like a turbulence rating for your glucose levels β the higher the %CV, the more unpredictable your blood sugar.
Key Findings in Plain English
The study identified specific %CV thresholds that corresponded to meaningful hypoglycemia risk levels:
- A %CV of 37.0% corresponded to a moderate hypoglycemia risk (Low Blood Glucose Index β₯ 2.5)
- A %CV of 42.2% corresponded to a high hypoglycemia risk (Low Blood Glucose Index > 5)
- A %CV of 40.7% was associated with actual severe hypoglycemia episodes β the kind requiring assistance from another person
In practical terms, blood sugar below 70 mg/dL is the standard threshold for hypoglycemia in the US, and severe hypoglycemia β where a person cannot treat themselves β is one of the most feared complications in T1D management.
How This Compares to US Guidelines
The American Diabetes Association (ADA) currently recommends keeping %CV below 36% as a marker of stable, manageable glucose variability. The Japanese findings closely align with this benchmark, suggesting that when %CV climbs above 37β42%, clinicians and patients should treat this as a red flag for impending dangerous lows β not just general instability.
Why This Matters for US Patients
For the roughly 1.6 million Americans living with Type 1 diabetes, preventing severe hypoglycemia is a daily concern. Many already use CGMs like the Dexcom G7 or Abbott FreeStyle Libre, which can display %CV metrics. This Japanese research suggests that paying close attention to your %CV β not just your average glucose or time-in-range β could serve as an early warning system before a dangerous low actually occurs.
If your CGM app shows a %CV creeping above 37β40%, this study suggests it may be time to talk with your endocrinologist or diabetes care team about adjusting your insulin regimen, reviewing carbohydrate ratios, or reassessing overnight basal rates.
The international perspective is valuable here because Japan's rigorous use of blinded CGM data in a controlled trial design provides a level of objectivity difficult to achieve in routine US clinical settings. These findings reinforce that glucose variability metrics are a universal language in diabetes care.
Study Citation
Murata, Matsuhisa, Kuroda. "The Relationship Between the Percent Coefficient of Variation of Sensor Glucose Levels and the Risk of Severe Hypoglycemia or Non-Severe Hypoglycemia in Patients With Type 1 Diabetes: Post Hoc Analysis of the ISCHIA Study." Journal of Diabetes Science and Technology, 2026. PMID: 39960254. DOI: 10.1177/19322968251318756
